Toggle

Seven drugs (bortezomib, clofarabine, cyclophosphamide, dexamethasone, etoposide, liposomal vincristine, and rituximab or ofatumumab) to treat acute leukemia or lymphoma that has come back (relapsed) or has not gotten better with treatment (refractory)

Print

15 and older

Phase 2

1 Location

NCT03136146

Clinical Trial Goal


To find out:
  • The highest doses of bortezomib, clofarabine, cyclophosphamide, etoposide, liposomal vincristine and that are safe to give
  • If this combination of drugs is safe and works well to treat acute leukemia or lymphoma that has relapsed or is refractory 

You may be able to join this trial if you:


  • Are 15 years old or older
  • Have one of the following diseases that has relapsed or is refractory:
    • Acute lymphoblastic leukemia (ALL)
    • Burkitt leukemia or lymphoma
    • Double-hit leukemia or lymphoma
    • Lymphoblastic lymphoma 
  • Agree to have other standard tests done to see if you can be in the clinical trial

Trial Details


There are 2 parts to this trial: Phase 1 and Phase 2. You will be in Phase 1 or Phase 2, but not both. Which phase you are in depends on when you start the trial.
  • Phase 1 – The doses of the 7 drugs you get will depend on how many patients have already been treated with them and how safe they have been
  • Phase 2 – The doses of the 7 drugs you get will be the highest doses shown to be safe in Phase 1

First, you’ll get induction therapy for 1 or 2 months. During induction, you'll get:
  • Bortezomib – Given as a shot under the skin 2 times each week for the first 2 weeks of each month
  • Clofarabine – Given as an intravenous (IV) infusion 1 time each day for the first 5 days of each month. Each infusion takes 1 – 2 hours.
  • Cyclophosphamide – Given as an IV infusion 1 time each day for 5 days. Each infusion takes about 1 hour.
  • Dexamethasone – Given as an IV infusion or a pill that you take by mouth each day for the first 5 days of each month. Each infusion takes about 15 minutes.
  • Etoposide – Given as an IV infusion 1 time each day for the first 5 days of each month. Each infusion takes about 2 hours.
  • Liposomal vincristine – Given as an IV infusion 1 time each week for the first 2 weeks of each month. Each infusion takes about 1 hour.
  • Ofatumumab or rituximab – Given as an IV infusion 1 time each week for the first 2 weeks of each month. Each infusion takes 4 – 24 hours.

You’ll also get pegfilgrastim, given as a shot under the skin 1 time each month, to help your bone marrow recover. 

Next, you’ll get consolidation therapy for 5 months. During consolidation therapy, you'll get:
  • Bortezomib – Given as a shot under the skin 2 times each week for the first 2 weeks of each month
  • Clofarabine – Given as an IV infusion 1 time each day for the first 4 days of each month. Each infusion takes 1 – 2 hours.
  • Cyclophosphamide – Given as an IV infusion 1 time each day for the first 4 days of each month. Each infusion takes about 1 hour.
  • Dexamethasone – Given as an IV infusion or a pill that you take by mouth each day for the first 5 days of each month. Each infusion takes about 15 minutes.
  • Etoposide – Given as an IV infusion 1 time each day for the first 4 days of each month. Each infusion takes about 2 hours.
  • Liposomal vincristine – Given as an IV infusion 1 time each week for the first 2 weeks of each month. Each infusion takes about 1 hour.
  • Ofatumumab or rituximab – Given as an IV infusion 1 time each week for the first 2 weeks of the first 4 months. Each infusion takes 4 – 24 hours. You’ll only get ofatumumab or rituximab if the clinical trial doctors think it's best for your health.

You’ll also get pegfilgrastim, given as a shot under the skin 1 time each month, to help your bone marrow recover. 

You might get some other drugs if the clinical trial doctors think it's best for your health. You’ll have bone marrow biopsies and scans to see how well the treatment is working. The doctors will check your health for up to 8 years.

The Food and Drug Administration (FDA) has approved all the drugs used in this trial. Using them together in this way with different doses to treat acute leukemia or lymphoma is new and unproven.

Locations


M D Anderson Cancer CenterRECRUITING

Houston, Texas
Maro Ohanian, 713-745-0394, MOhanian@mdanderson.org

ClinicalTrials.gov record


NCT03136146. First posted on 5/2/17

Call center employee on the phone offering help to a caller

Questions? Contact our Clinical Trials Navigator

1-888-814-8610
contact@ctsearchsupport.org